Booth Bruce
Insider CIK 1451612 · ZFGN Director, 10% owner · MGEN Director · UMRX Director · AVRO Director · MGTA Director · KYMR Director · VIGL Director · SION Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-06-29 | 2026-07-02 | 934 | $111.20 | $103.9K | 2,384,685 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-06-29 | 2026-07-02 | 5,549 | $105.78 | $587.0K | 2,446,375 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-06-29 | 2026-07-02 | 14,798 | $106.63 | $1.58M | 2,431,577 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-06-29 | 2026-07-02 | 19,419 | $107.76 | $2.09M | 2,412,158 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-06-29 | 2026-07-02 | 130 | $111.20 | $14.5K | 462,856 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-06-29 | 2026-07-02 | 1,078 | $110.67 | $119.3K | 462,986 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-06-29 | 2026-07-02 | 1,104 | $109.75 | $121.2K | 464,064 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-06-29 | 2026-07-02 | 1,498 | $108.28 | $162.2K | 465,168 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-06-29 | 2026-07-02 | 2,698 | $107.76 | $290.7K | 466,666 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-06-29 | 2026-07-02 | 2,133 | $106.63 | $227.4K | 469,364 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-06-29 | 2026-07-02 | 770 | $105.78 | $81.5K | 471,497 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-06-29 | 2026-07-02 | 7,723 | $110.67 | $854.7K | 2,385,619 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-06-29 | 2026-07-02 | 7,968 | $109.75 | $874.5K | 2,393,342 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-06-29 | 2026-07-02 | 10,848 | $108.28 | $1.17M | 2,401,310 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-06-29 | 2026-06-30 | 3,024 | $107.76 | $325.9K | 466,077 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-06-29 | 2026-06-30 | 2,318 | $106.63 | $247.2K | 469,101 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-06-29 | 2026-06-30 | 848 | $105.78 | $89.7K | 471,419 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-06-29 | 2026-06-30 | 19,093 | $107.76 | $2.06M | 2,412,747 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-06-29 | 2026-06-30 | 14,613 | $106.63 | $1.56M | 2,431,840 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-06-29 | 2026-06-30 | 5,471 | $105.78 | $578.7K | 2,446,453 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-06-29 | 2026-06-30 | 1,239 | $109.75 | $136.0K | 463,150 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-06-29 | 2026-06-30 | 1,688 | $108.28 | $182.8K | 464,389 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-06-29 | 2026-06-30 | 907 | $111.20 | $100.9K | 2,385,747 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-06-29 | 2026-06-30 | 7,602 | $110.67 | $841.3K | 2,386,654 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-06-29 | 2026-06-30 | 1,199 | $110.67 | $132.7K | 461,951 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-06-29 | 2026-06-30 | 157 | $111.20 | $17.5K | 461,794 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-06-29 | 2026-06-30 | 7,833 | $109.75 | $859.7K | 2,394,256 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-06-29 | 2026-06-30 | 10,658 | $108.28 | $1.15M | 2,402,089 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-06-26 | 2026-06-30 | 1,729 | $118.66 | $205.2K | 472,267 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-06-26 | 2026-06-30 | 3,069 | $117.85 | $361.7K | 473,996 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-06-26 | 2026-06-30 | 1,701 | $117.09 | $199.2K | 477,065 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-06-26 | 2026-06-30 | 952 | $115.69 | $110.1K | 478,766 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-06-26 | 2026-06-30 | 3,896 | $114.94 | $447.8K | 479,718 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-06-26 | 2026-06-30 | 2,083 | $113.97 | $237.4K | 483,614 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-06-26 | 2026-06-30 | 78 | $112.49 | $8.8K | 485,697 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-06-26 | 2026-06-30 | 1,442 | $111.51 | $160.8K | 485,775 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-06-26 | 2026-06-30 | 1,579 | $110.49 | $174.5K | 487,217 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-06-26 | 2026-06-30 | 4,562 | $109.79 | $500.9K | 488,796 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-06-26 | 2026-06-30 | 32,402 | $108.14 | $3.50M | 493,358 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-06-26 | 2026-06-30 | 3,958 | $107.57 | $425.8K | 525,760 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-06-26 | 2026-06-30 | 12,390 | $118.66 | $1.47M | 2,451,924 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-06-26 | 2026-06-30 | 22,046 | $117.85 | $2.60M | 2,464,314 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-06-26 | 2026-06-30 | 12,181 | $117.09 | $1.43M | 2,486,360 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-06-26 | 2026-06-30 | 6,821 | $115.69 | $789.1K | 2,498,541 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-06-26 | 2026-06-30 | 27,951 | $114.94 | $3.21M | 2,505,362 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-06-26 | 2026-06-30 | 14,913 | $113.97 | $1.70M | 2,533,313 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-06-26 | 2026-06-30 | 555 | $112.49 | $62.4K | 2,548,226 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-06-26 | 2026-06-30 | 10,366 | $111.51 | $1.16M | 2,548,781 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-06-26 | 2026-06-30 | 11,277 | $110.49 | $1.25M | 2,559,147 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-06-26 | 2026-06-30 | 32,624 | $109.79 | $3.58M | 2,570,424 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-06-26 | 2026-06-30 | 231,007 | $108.14 | $24.98M | 2,603,048 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-06-26 | 2026-06-30 | 28,296 | $107.57 | $3.04M | 2,834,055 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-06-25 | 2026-06-25 | 159 | $108.02 | $17.2K | 3,333,190 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-06-25 | 2026-06-25 | 9,994 | $107.30 | $1.07M | 3,333,349 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-06-25 | 2026-06-25 | 2,646 | $118.60 | $313.8K | 564,668 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-06-25 | 2026-06-25 | 3,359 | $117.50 | $394.7K | 567,314 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-06-25 | 2026-06-25 | 11,375 | $116.53 | $1.33M | 570,673 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-06-25 | 2026-06-25 | 8,389 | $115.57 | $969.5K | 582,048 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-06-25 | 2026-06-25 | 1,289 | $114.65 | $147.8K | 590,437 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-06-25 | 2026-06-25 | 1,437 | $113.70 | $163.4K | 591,726 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-06-25 | 2026-06-25 | 100 | $111.89 | $11.2K | 593,163 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-06-25 | 2026-06-25 | 14,351 | $108.83 | $1.56M | 3,318,839 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-06-25 | 2026-06-25 | 1,915 | $110.30 | $211.2K | 3,316,924 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-06-25 | 2026-06-25 | 614 | $110.79 | $68.0K | 3,316,310 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-06-25 | 2026-06-25 | 719 | $111.89 | $80.4K | 3,315,591 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-06-25 | 2026-06-25 | 10,215 | $113.70 | $1.16M | 3,305,376 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-06-25 | 2026-06-25 | 9,229 | $114.65 | $1.06M | 3,296,147 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-06-25 | 2026-06-25 | 58,205 | $115.57 | $6.73M | 3,237,942 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-06-25 | 2026-06-25 | 81,500 | $116.53 | $9.50M | 3,156,442 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-06-25 | 2026-06-25 | 24,268 | $117.50 | $2.85M | 3,132,174 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-06-25 | 2026-06-25 | 19,089 | $118.60 | $2.26M | 3,113,085 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-06-25 | 2026-06-25 | 1,399 | $107.30 | $150.1K | 595,648 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-06-25 | 2026-06-25 | 23 | $108.02 | $2.5K | 595,625 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-06-25 | 2026-06-25 | 2,011 | $108.83 | $218.9K | 593,614 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-06-25 | 2026-06-25 | 86 | $110.79 | $9.5K | 593,263 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-06-25 | 2026-06-25 | 265 | $110.30 | $29.2K | 593,349 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-06-25 | 2026-06-25 | 3,507 | $127.37 | $446.7K | 530,069 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-06-25 | 2026-06-25 | 223 | $126.71 | $28.3K | 533,576 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-06-25 | 2026-06-25 | 522 | $125.82 | $65.7K | 533,799 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-06-25 | 2026-06-25 | 1,639 | $124.61 | $204.2K | 534,321 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-06-25 | 2026-06-25 | 1,517 | $123.62 | $187.5K | 535,960 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-06-25 | 2026-06-25 | 698 | $122.67 | $85.6K | 537,477 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-06-25 | 2026-06-25 | 5,689 | $121.38 | $690.5K | 538,175 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-06-25 | 2026-06-25 | 15,660 | $120.66 | $1.89M | 543,864 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-06-25 | 2026-06-25 | 5,144 | $119.71 | $615.8K | 559,524 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-06-25 | 2026-06-25 | 337 | $129.61 | $43.7K | 2,862,351 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-06-25 | 2026-06-25 | 2,197 | $128.69 | $282.7K | 2,862,688 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-06-25 | 2026-06-25 | 25,075 | $127.37 | $3.19M | 2,864,885 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-06-25 | 2026-06-25 | 1,609 | $126.71 | $203.9K | 2,889,960 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-06-25 | 2026-06-25 | 3,716 | $125.82 | $467.5K | 2,891,569 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-06-25 | 2026-06-25 | 11,711 | $124.61 | $1.46M | 2,895,285 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-06-25 | 2026-06-25 | 10,860 | $123.62 | $1.34M | 2,906,996 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-06-25 | 2026-06-25 | 4,977 | $122.67 | $610.5K | 2,917,856 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-06-25 | 2026-06-25 | 40,774 | $121.38 | $4.95M | 2,922,833 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-06-25 | 2026-06-25 | 112,299 | $120.66 | $13.55M | 2,963,607 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-06-25 | 2026-06-25 | 37,179 | $119.71 | $4.45M | 3,075,906 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-06-25 | 2026-06-25 | 46 | $129.61 | $6.0K | 529,718 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-06-25 | 2026-06-25 | 305 | $128.69 | $39.3K | 529,764 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | A Award deriv | 2026-06-24 | 2026-06-25 | 6,068 | — | $0 | 6,068 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-06-24 | 2026-06-25 | 2,029 | $101.14 | $205.2K | 597,047 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-06-24 | 2026-06-25 | 14,490 | $101.14 | $1.47M | 3,343,343 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-06-24 | 2026-06-25 | 14,513 | $100.42 | $1.46M | 599,076 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-06-24 | 2026-06-25 | 103,688 | $100.42 | $10.41M | 3,357,833 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-06-23 | 2026-06-25 | 173 | $99.98 | $17.3K | 613,589 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-06-23 | 2026-06-25 | 1,235 | $99.98 | $123.5K | 3,461,521 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-06-22 | 2026-06-22 | 1,253 | $102.48 | $128.4K | 617,663 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-06-22 | 2026-06-22 | 918 | $101.61 | $93.3K | 618,916 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-06-22 | 2026-06-22 | 7,879 | $100.17 | $789.2K | 619,834 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-06-22 | 2026-06-22 | 7,319 | $99.57 | $728.8K | 627,713 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-06-22 | 2026-06-22 | 3,603 | $98.58 | $355.2K | 635,032 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-06-22 | 2026-06-22 | 2,247 | $97.68 | $219.5K | 638,635 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-06-22 | 2026-06-22 | 2,919 | $96.24 | $280.9K | 640,882 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-06-22 | 2026-06-22 | 1,648 | $95.12 | $156.8K | 643,801 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-06-22 | 2026-06-22 | 286 | $94.48 | $27.0K | 645,449 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-06-22 | 2026-06-22 | 2,179 | $92.14 | $200.8K | 645,735 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-06-22 | 2026-06-22 | 8,990 | $102.48 | $921.3K | 3,490,653 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-06-22 | 2026-06-22 | 6,597 | $101.61 | $670.3K | 3,499,643 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-06-22 | 2026-06-22 | 56,348 | $100.17 | $5.64M | 3,506,240 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-06-22 | 2026-06-22 | 52,442 | $99.57 | $5.22M | 3,562,588 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-06-22 | 2026-06-22 | 25,976 | $98.58 | $2.56M | 3,615,030 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-06-22 | 2026-06-22 | 16,084 | $97.68 | $1.57M | 3,641,006 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-06-22 | 2026-06-22 | 20,903 | $96.24 | $2.01M | 3,657,090 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-06-22 | 2026-06-22 | 11,783 | $95.12 | $1.12M | 3,677,993 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-06-22 | 2026-06-22 | 2,035 | $94.48 | $192.3K | 3,689,776 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-06-22 | 2026-06-22 | 14,921 | $92.14 | $1.37M | 3,691,811 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-06-22 | 2026-06-22 | 9,584 | $104.38 | $1.00M | 3,462,756 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-06-22 | 2026-06-22 | 18,313 | $103.42 | $1.89M | 3,472,340 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-06-22 | 2026-06-22 | 2,560 | $103.42 | $264.8K | 615,103 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-06-22 | 2026-06-22 | 1,341 | $104.38 | $140.0K | 613,762 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-06-18 | 2026-06-22 | 62,897 | $90.48 | $5.69M | 3,744,763 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-06-18 | 2026-06-22 | 8,809 | $90.48 | $797.0K | 653,233 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-06-18 | 2026-06-22 | 793 | $92.16 | $73.1K | 647,914 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-06-18 | 2026-06-22 | 4,526 | $91.85 | $415.7K | 648,707 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-06-18 | 2026-06-22 | 32,359 | $91.85 | $2.97M | 3,712,404 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-06-18 | 2026-06-22 | 5,672 | $92.16 | $522.7K | 3,706,732 | SEC↗ |
| SION Sionna Therapeutics, Inc. | A Award deriv | 2026-06-17 | 2026-06-18 | 17,340 | — | $0 | 17,340 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise deriv | 2026-06-17 | 2026-06-22 | 11,741 | — | $0 | 28,127 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise | 2026-06-17 | 2026-06-22 | 11,741 | $20.00 | $234.8K | 11,741 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-06-17 | 2026-06-22 | 11,741 | $89.98 | $1.06M | 0 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-06-17 | 2026-06-22 | 92,169 | $90.38 | $8.33M | 3,807,660 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-06-17 | 2026-06-22 | 12,902 | $90.38 | $1.17M | 662,042 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise deriv | 2026-04-22 | 2026-04-24 | 5,641 | — | $0 | 0 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise deriv | 2026-04-22 | 2026-04-24 | 259 | — | $0 | 39,868 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise | 2026-04-22 | 2026-04-24 | 259 | $20.00 | $5.2K | 5,900 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-04-22 | 2026-04-24 | 12 | $90.08 | $1.1K | 674,944 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-04-22 | 2026-04-24 | 5,900 | $89.96 | $530.8K | 0 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-04-22 | 2026-04-24 | 88 | $90.08 | $7.9K | 3,899,829 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise | 2026-04-22 | 2026-04-24 | 5,641 | $14.18 | $80.0K | 5,641 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise deriv | 2026-04-15 | 2026-04-16 | 2,200 | — | $0 | 5,641 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-04-15 | 2026-04-16 | 385 | $90.10 | $34.7K | 674,956 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-04-15 | 2026-04-16 | 2,750 | $90.10 | $247.8K | 3,899,917 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-04-15 | 2026-04-16 | 2,200 | $89.95 | $197.9K | 0 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise | 2026-04-15 | 2026-04-16 | 2,200 | $14.18 | $31.2K | 2,200 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise deriv | 2026-04-14 | 2026-04-16 | 4,159 | — | $0 | 7,841 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-04-14 | 2026-04-16 | 4,159 | $89.97 | $374.2K | 0 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise | 2026-04-14 | 2026-04-16 | 4,159 | $14.18 | $59.0K | 4,159 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-03-02 | 2026-03-04 | 71,814 | $90.13 | $6.47M | 3,902,667 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-03-02 | 2026-03-04 | 10,052 | $90.13 | $906.0K | 675,341 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2025-12-12 | 2025-12-12 | 108 | $91.04 | $9.8K | 685,393 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2025-12-12 | 2025-12-12 | 570 | $91.04 | $51.9K | 3,974,481 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2025-12-11 | 2025-12-12 | 976 | $91.23 | $89.0K | 685,501 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2025-12-11 | 2025-12-12 | 5,125 | $91.23 | $467.6K | 3,975,051 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2025-12-10 | 2025-12-12 | 10,545 | $90.14 | $950.5K | 4,113,387 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2025-12-10 | 2025-12-12 | 9,060 | $92.41 | $837.2K | 702,815 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2025-12-10 | 2025-12-12 | 2,001 | $90.14 | $180.4K | 711,875 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2025-12-10 | 2025-12-12 | 3,391 | $89.25 | $302.6K | 713,876 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2025-12-10 | 2025-12-12 | 5,979 | $88.64 | $530.0K | 717,267 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2025-12-10 | 2025-12-12 | 85,862 | $93.20 | $8.00M | 3,980,176 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2025-12-10 | 2025-12-12 | 47,349 | $92.41 | $4.38M | 4,066,038 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2025-12-10 | 2025-12-12 | 16,338 | $93.20 | $1.52M | 686,477 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2025-12-10 | 2025-12-12 | 17,825 | $89.25 | $1.59M | 4,123,932 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2025-12-10 | 2025-12-12 | 31,459 | $88.64 | $2.79M | 4,141,757 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2025-10-21 | 2025-10-21 | 22,339 | $32.69 | $730.3K | 2,360,156 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2025-10-21 | 2025-10-21 | 4,688 | $32.69 | $153.3K | 697,297 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2025-10-21 | 2025-10-21 | 19,948 | $33.87 | $675.6K | 2,340,208 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2025-10-21 | 2025-10-21 | 4,187 | $33.87 | $141.8K | 693,110 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2025-10-21 | 2025-10-21 | 5,763 | $34.91 | $201.2K | 2,334,445 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2025-10-21 | 2025-10-21 | 1,210 | $34.91 | $42.2K | 691,900 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2025-10-21 | 2025-10-21 | 25,327 | $35.69 | $903.9K | 2,309,118 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2025-10-21 | 2025-10-21 | 5,316 | $35.69 | $189.7K | 686,584 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2025-10-21 | 2025-10-21 | 17 | $36.42 | $619 | 686,567 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2025-10-21 | 2025-10-21 | 83 | $36.42 | $3.0K | 2,309,035 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2025-10-20 | 2025-10-20 | 20,485 | $31.79 | $651.2K | 2,408,283 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2025-10-20 | 2025-10-20 | 4,300 | $31.79 | $136.7K | 707,397 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2025-10-20 | 2025-10-20 | 25,788 | $32.33 | $833.7K | 2,382,495 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2025-10-20 | 2025-10-20 | 5,412 | $32.33 | $175.0K | 701,985 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2025-10-17 | 2025-10-20 | 248 | $33.47 | $8.3K | 2,428,768 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2025-10-17 | 2025-10-20 | 4,503 | $32.71 | $147.3K | 711,749 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2025-10-17 | 2025-10-20 | 21,451 | $32.71 | $701.7K | 2,429,016 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2025-10-17 | 2025-10-20 | 6,049 | $32.10 | $194.2K | 716,252 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2025-10-17 | 2025-10-20 | 28,821 | $32.10 | $925.2K | 2,450,467 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2025-10-17 | 2025-10-20 | 52 | $33.47 | $1.7K | 711,697 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2025-10-16 | 2025-10-20 | 12,888 | $33.38 | $430.2K | 2,479,288 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2025-10-16 | 2025-10-20 | 8,596 | $30.15 | $259.2K | 2,610,589 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2025-10-16 | 2025-10-20 | 1,804 | $30.15 | $54.4K | 749,860 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2025-10-16 | 2025-10-20 | 45,117 | $31.69 | $1.43M | 2,565,472 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2025-10-16 | 2025-10-20 | 9,470 | $31.69 | $300.1K | 740,390 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2025-10-16 | 2025-10-20 | 73,296 | $32.84 | $2.41M | 2,492,176 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2025-10-16 | 2025-10-20 | 15,384 | $32.84 | $505.2K | 725,006 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2025-10-16 | 2025-10-20 | 2,705 | $33.38 | $90.3K | 722,301 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2025-10-15 | 2025-10-15 | 65,726 | $30.37 | $2.00M | 2,649,217 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2025-10-15 | 2025-10-15 | 13,795 | $30.37 | $419.0K | 757,967 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2025-10-15 | 2025-10-15 | 30,032 | $31.12 | $934.6K | 2,619,185 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2025-10-15 | 2025-10-15 | 6,303 | $31.12 | $196.1K | 751,664 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2025-10-14 | 2025-10-15 | 105 | $29.95 | $3.1K | 771,762 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2025-10-14 | 2025-10-15 | 501 | $29.95 | $15.0K | 2,714,943 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2025-10-13 | 2025-10-15 | 857 | $31.03 | $26.6K | 771,867 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2025-10-13 | 2025-10-15 | 4,082 | $31.03 | $126.7K | 2,715,444 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2025-10-13 | 2025-10-15 | 9,245 | $30.32 | $280.3K | 772,724 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2025-10-13 | 2025-10-15 | 44,048 | $30.32 | $1.34M | 2,719,526 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2025-10-10 | 2025-10-15 | 3,511 | $29.98 | $105.3K | 781,969 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2025-10-10 | 2025-10-15 | 16,727 | $29.98 | $501.5K | 2,763,574 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2025-10-06 | 2025-10-07 | 9,753 | $29.95 | $292.1K | 2,780,301 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2025-10-06 | 2025-10-07 | 2,047 | $29.95 | $61.3K | 785,480 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2025-10-03 | 2025-10-07 | 6,548 | $30.00 | $196.4K | 787,527 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2025-10-03 | 2025-10-07 | 31,198 | $30.00 | $935.9K | 2,790,054 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2025-10-01 | 2025-10-01 | 165 | $29.95 | $4.9K | 2,821,252 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2025-10-01 | 2025-10-01 | 35 | $29.95 | $1.0K | 794,075 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2025-09-30 | 2025-10-01 | 2,149 | $30.06 | $64.6K | 794,110 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2025-09-30 | 2025-10-01 | 10,239 | $30.06 | $307.8K | 2,821,417 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2025-09-29 | 2025-10-01 | 54,637 | $30.09 | $1.64M | 2,831,656 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2025-09-29 | 2025-10-01 | 11,468 | $30.09 | $345.1K | 796,259 | SEC↗ |
| VIGL Vigil Neuroscience, Inc. | D To issuer deriv | 2025-08-05 | 2025-08-05 | 7,577 | — | $0 | 0 | SEC↗ |
| VIGL Vigil Neuroscience, Inc. | D To issuer deriv | 2025-08-05 | 2025-08-05 | 12,155 | — | $0 | 0 | SEC↗ |
| VIGL Vigil Neuroscience, Inc. | D To issuer deriv | 2025-08-05 | 2025-08-05 | 9,713 | — | $0 | 0 | SEC↗ |
| VIGL Vigil Neuroscience, Inc. | D To issuer deriv | 2025-08-05 | 2025-08-05 | 13,928 | — | $0 | 0 | SEC↗ |
| VIGL Vigil Neuroscience, Inc. | D To issuer deriv | 2025-08-05 | 2025-08-05 | 34,612 | — | $0 | 0 | SEC↗ |
| VIGL Vigil Neuroscience, Inc. | D To issuer deriv | 2025-08-05 | 2025-08-05 | 48,393 | — | $0 | 0 | SEC↗ |
| VIGL Vigil Neuroscience, Inc. | D To issuer deriv | 2025-08-05 | 2025-08-05 | 18,068 | — | $0 | 0 | SEC↗ |
| VIGL Vigil Neuroscience, Inc. | D To issuer | 2025-08-05 | 2025-08-05 | 5,000 | — | $0 | 0 | SEC↗ |
| VIGL Vigil Neuroscience, Inc. | D To issuer | 2025-08-05 | 2025-08-05 | 1,027,978 | — | $0 | 0 | SEC↗ |
| VIGL Vigil Neuroscience, Inc. | D To issuer | 2025-08-05 | 2025-08-05 | 4,808,896 | — | $0 | 0 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | A Award deriv | 2025-06-25 | 2025-06-26 | 16,000 | — | $0 | 16,000 | SEC↗ |
| SION Sionna Therapeutics, Inc. | A Award deriv | 2025-06-12 | 2025-06-16 | 19,959 | — | $0 | 19,959 | SEC↗ |
| VIGL Vigil Neuroscience, Inc. | A Award | 2025-05-22 | 2025-05-23 | 5,000 | — | $0 | 5,000 | SEC↗ |
| VIGL Vigil Neuroscience, Inc. | A Award deriv | 2025-03-03 | 2025-03-04 | 48,393 | — | $0 | 48,393 | SEC↗ |
| SION Sionna Therapeutics, Inc. | C Conversion deriv | 2025-02-10 | 2025-02-10 | 1,051,051 | — | $0 | 0 | SEC↗ |
| SION Sionna Therapeutics, Inc. | C Conversion deriv | 2025-02-10 | 2025-02-10 | 1,806,317 | — | $0 | 0 | SEC↗ |
| SION Sionna Therapeutics, Inc. | C Conversion deriv | 2025-02-10 | 2025-02-10 | 1,298,332 | — | $0 | 0 | SEC↗ |
| SION Sionna Therapeutics, Inc. | C Conversion deriv | 2025-02-10 | 2025-02-10 | 61,463 | — | $0 | 0 | SEC↗ |
| SION Sionna Therapeutics, Inc. | C Conversion deriv | 2025-02-10 | 2025-02-10 | 1,092,504 | — | $0 | 0 | SEC↗ |
| SION Sionna Therapeutics, Inc. | C Conversion | 2025-02-10 | 2025-02-10 | 2,886,293 | — | $0 | 2,886,293 | SEC↗ |
| SION Sionna Therapeutics, Inc. | C Conversion | 2025-02-10 | 2025-02-10 | 747,727 | — | $0 | 747,727 | SEC↗ |
| SION Sionna Therapeutics, Inc. | P Buy | 2025-02-10 | 2025-02-10 | 60,000 | $18.00 | $1.08M | 807,727 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2024-07-09 | 2024-07-09 | 24,449 | $35.57 | $869.7K | 4,523,951 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2024-07-09 | 2024-07-09 | 28,718 | $36.40 | $1.05M | 4,495,233 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2024-07-09 | 2024-07-09 | 41,763 | $37.41 | $1.56M | 4,453,470 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2024-07-09 | 2024-07-09 | 183,868 | $38.48 | $7.08M | 4,269,602 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2024-07-09 | 2024-07-09 | 20,238 | $39.26 | $794.5K | 723,246 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2024-07-09 | 2024-07-09 | 38,606 | $38.48 | $1.49M | 743,484 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2024-07-09 | 2024-07-09 | 8,769 | $37.41 | $328.0K | 782,090 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2024-07-09 | 2024-07-09 | 6,030 | $36.40 | $219.5K | 790,859 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2024-07-09 | 2024-07-09 | 5,133 | $35.57 | $182.6K | 796,889 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2024-07-09 | 2024-07-09 | 96,386 | $39.26 | $3.78M | 4,173,216 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | A Award deriv | 2024-06-18 | 2024-06-20 | 16,000 | — | $0 | 16,000 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2024-06-13 | 2024-06-14 | 8,430 | $34.98 | $294.9K | 4,548,400 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2024-06-13 | 2024-06-14 | 1,770 | $34.98 | $61.9K | 802,022 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2024-06-12 | 2024-06-14 | 11,838 | $35.35 | $418.5K | 4,558,827 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2024-06-12 | 2024-06-14 | 1,997 | $36.02 | $71.9K | 4,556,830 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2024-06-12 | 2024-06-14 | 2,485 | $35.35 | $87.8K | 804,212 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2024-06-12 | 2024-06-14 | 420 | $36.02 | $15.1K | 803,792 | SEC↗ |
| VIGL Vigil Neuroscience, Inc. | A Award deriv | 2024-06-05 | 2024-06-07 | 18,068 | — | $0 | 18,068 | SEC↗ |
| VIGL Vigil Neuroscience, Inc. | A Award deriv | 2024-05-03 | 2024-05-07 | 9,713 | — | $0 | 9,713 | SEC↗ |
| VIGL Vigil Neuroscience, Inc. | A Award deriv | 2024-05-03 | 2024-05-07 | 13,928 | — | $0 | 13,928 | SEC↗ |
| VIGL Vigil Neuroscience, Inc. | D To issuer deriv | 2024-05-03 | 2024-05-07 | 13,928 | — | $0 | 0 | SEC↗ |
| VIGL Vigil Neuroscience, Inc. | D To issuer deriv | 2024-05-03 | 2024-05-07 | 7,577 | $9.63 | $73.0K | 0 | SEC↗ |
| VIGL Vigil Neuroscience, Inc. | D To issuer deriv | 2024-05-03 | 2024-05-07 | 12,155 | — | $0 | 0 | SEC↗ |
| VIGL Vigil Neuroscience, Inc. | A Award deriv | 2024-05-03 | 2024-05-07 | 12,155 | — | $0 | 12,155 | SEC↗ |
| VIGL Vigil Neuroscience, Inc. | D To issuer deriv | 2024-05-03 | 2024-05-07 | 9,713 | $7.62 | $74.0K | 0 | SEC↗ |
| VIGL Vigil Neuroscience, Inc. | A Award deriv | 2024-05-03 | 2024-05-07 | 7,577 | — | $0 | 7,577 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2024-03-15 | 2024-03-15 | 10,411 | $40.62 | $422.9K | 807,026 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2024-03-15 | 2024-03-15 | 1,714 | $39.31 | $67.4K | 817,437 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2024-03-15 | 2024-03-15 | 1,593 | $41.23 | $65.7K | 4,570,665 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2024-03-15 | 2024-03-15 | 49,591 | $40.62 | $2.01M | 4,572,258 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2024-03-15 | 2024-03-15 | 8,126 | $39.31 | $319.4K | 4,621,849 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2024-03-15 | 2024-03-15 | 329 | $41.23 | $13.6K | 806,697 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2024-03-14 | 2024-03-15 | 154 | $41.51 | $6.4K | 819,151 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2024-03-14 | 2024-03-15 | 2,233 | $40.66 | $90.8K | 819,305 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2024-03-14 | 2024-03-15 | 7,292 | $39.73 | $289.7K | 821,538 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2024-03-14 | 2024-03-15 | 781 | $41.51 | $32.4K | 4,629,975 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2024-03-14 | 2024-03-15 | 10,846 | $40.66 | $441.0K | 4,630,756 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2024-03-14 | 2024-03-15 | 34,473 | $39.73 | $1.37M | 4,641,602 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2024-03-13 | 2024-03-13 | 1,386 | $42.84 | $59.4K | 828,830 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2024-03-13 | 2024-03-13 | 22,779 | $42.19 | $961.0K | 830,216 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2024-03-13 | 2024-03-13 | 6,686 | $42.84 | $286.4K | 4,676,075 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2024-03-13 | 2024-03-13 | 108,404 | $42.19 | $4.57M | 4,682,761 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2024-03-12 | 2024-03-13 | 126,066 | $41.94 | $5.29M | 4,799,746 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2024-03-12 | 2024-03-13 | 1,819 | $42.52 | $77.3K | 852,995 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2024-03-12 | 2024-03-13 | 26,452 | $41.94 | $1.11M | 854,814 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2024-03-12 | 2024-03-13 | 8,581 | $42.52 | $364.9K | 4,791,165 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2024-03-11 | 2024-03-13 | 5,122 | $43.42 | $222.4K | 4,925,812 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2024-03-11 | 2024-03-13 | 37,180 | $42.77 | $1.59M | 4,930,934 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2024-03-11 | 2024-03-13 | 7,837 | $42.77 | $335.2K | 882,311 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2024-03-11 | 2024-03-13 | 1,045 | $43.42 | $45.4K | 881,266 | SEC↗ |
| VIGL Vigil Neuroscience, Inc. | A Award deriv | 2024-03-01 | 2024-03-05 | 34,612 | — | $0 | 34,612 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | A Award deriv | 2023-06-15 | 2023-06-20 | 12,000 | — | $0 | 12,000 | SEC↗ |
| VIGL Vigil Neuroscience, Inc. | A Award deriv | 2023-06-07 | 2023-06-09 | 13,928 | — | $0 | 13,928 | SEC↗ |
| AVRO AVROBIO, Inc. | A Award deriv | 2023-06-06 | 2023-06-08 | 17,643 | — | $0 | 17,643 | SEC↗ |
| VIGL Vigil Neuroscience, Inc. | A Award deriv | 2023-03-01 | 2023-03-03 | 9,713 | $7.62 | $74.0K | 9,713 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2023-01-12 | 2023-01-13 | 77,128 | $30.29 | $2.34M | 4,968,114 | SEC↗ |